The predicted risk of adverse pregnancy outcomes as a result of treatmentassociated obesity in a hypothetical population receiving tenofovir alafenamideemtricitabinedolutegravir tenofovir disoproxil fumarateemtricitabinedolutegravir or tenofovir diso

Sumbul AsifEvangelia BaxevanidiAndrew HillWillem VenterLee FairlieMasebole MasenyaCelicia SerenataSimiso SokhelaNomathemba Chandiwana2023-02-282023-02-28WOS0269-9370https://hdl.handle.net/10539/34702The predicted risk of adverse pregnancy outcomes as a result of treatmentassociated obesity in a hypothetical population receiving tenofovir alafenamideemtricitabinedolutegravir tenofovir disoproxil fumarateemtricitabinedolutegravir or tenofovir diso